文献速递甲状腺疾病

预测甲状腺乳头状癌生存:两个当代国家患者队列中美国癌症联合委员会/国际抗癌联盟第七版与第八版分期系统的比较

Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
PubMed 文献 · Thyroid · 2017-10-05

研究基于SEER(2004-2012)和国家癌症数据库(2004-2012)两个成人甲状腺乳头状癌手术患者队列,分别应用AJCC/UICC第七版和第八版分期标准,采用Kaplan-Meier法和多因素Cox比例风险模型分析分期与生存的关联,并用赤池信息准则评估模型表现。结果显示SEER中约23%、国家癌症数据库中24%的患者从第七版至第八版被降期;两版分期均与疾病特异性生存和总生存显著相关(p < 0.001);第八版分期模型对数据的拟合优于第七版(赤池信息准则值更小)。结论认为第八版AJCC/UICC分期在预测甲状腺乳头状癌生存方面优于第七版。

要点

  • SEER队列约23%、国家癌症数据库队列24%的甲状腺乳头状癌患者从第七版至第八版分期被降期。
  • 第七版和第八版分期均与疾病特异性生存和总生存显著相关(p < 0.001)。
  • 第八版分期模型对疾病特异性生存和总生存的拟合均优于第七版(赤池信息准则值更小)。

核心结论

  • 基于两个大型当代国家队列,第八版AJCC/UICC肿瘤、淋巴结、转移分类对甲状腺乳头状癌的生存预测优于第七版。

研究设计与样本

  • 从SEER项目(2004-2012)和国家癌症数据库(2004-2012)中选取接受手术的成人甲状腺乳头状癌患者。
  • 分别对每个队列应用第七版和第八版AJCC/UICC分期标准。
  • 采用Kaplan-Meier法估计生存概率,多因素Cox比例风险模型估计分期与生存的关联,赤池信息准则评估模型表现。

主要发现

  • SEER中约23%的患者从第七版至第八版被降期,国家癌症数据库中24%的患者被降期。
  • 使用第七版和第八版AJCC/UICC分期系统时,疾病特异性生存和总生存均与诊断时分期显著相关(p < 0.001)。
  • 第八版中分类为较高分期(III期和IV期)的患者预后差于第七版中分类为相似分期的患者。
  • 校正后,两版定义的甲状腺乳头状癌分期均与疾病特异性生存和总生存显著相关。
  • 就疾病特异性生存和总生存而言,第八版甲状腺乳头状癌模型对数据的拟合优于第七版(赤池信息准则值更小)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to compare the seventh and eighth editions of the American Joint Commission on Cancer/Union for International Cancer Control (AJCC/UICC) tumor, node, metastasis staging system for patients with papillary thyroid cancer (PTC) in two national patient cohorts. METHODS: Adult PTC patients undergoing surgery were selected from the Surveillance, Epidemiology and End Results (SEER) program (2004-2012) and the National Cancer Database (2004-2012). Staging criteria for the seventh and eighth AJCC/UICC editions were applied separately to each cohort. Survival probabilities were estimated using the Kaplan-Meier method. Multivariable Cox proportional hazards models were used to estimate the association of stage with survival in both settings. The Akaike information criterion was used to assess model performance. RESULTS: About 23% of patients were downstaged from the seventh to the eighth edition in SEER, while 24% were downstaged in the National Cancer Database. Disease-specific survival (DSS) and overall survival (OS) were significantly related to stage at diagnosis when using both the seventh and eighth editions of the AJCC/UICC staging system (p < 0.001). Patients classified into higher stages (III and IV) in the eighth edition showed a worse prognosis than those classified into similar stages in the seventh edition. After adjustment, PTC stages as defined by both editions were significantly associated with DSS and OS. With respect to both DSS and OS, the eighth edition PTC model appeared to be a better fit to the data (smaller Akaike information criterion values) compared to the seventh edition. CONCLUSION: Based on these large contemporary national cohorts, the eighth edition AJCC/UICC tumor, node, metastasis classification for PTC is superior to the seventh edition for predicting survival.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Pontius LN, Oyekunle TO, Thomas SM, et al. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. Thyroid. 2017. PMID: 28891405. doi:10.1089/thy.2017.0306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。